Search Result "lymphotoxic molecules"
Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 3191-3201
Author(s): Lara Sanvito, Cris S. Constantinescu, Bruno Gran
Azathioprine in Multiple Sclerosis
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 8 Issue: 9 Year: 2008 Page: 919-926
Author(s): Paolo Invernizz, Maria Donata Benedetti, Sarah Poli, Salvatore Monaco
Inflammation-Mediating Proteases: Structure, Function in (Patho) Physiology and Inhibition
Journal: Protein & Peptide Letters
Volume: 21 Issue: 12 Year: 2014 Page: 1209-1229
Author(s): Mateja Mancek-Keber
A Review on Novel Therapeutic Modalities and Evidence-based DrugTreatments against Allergic Rhinitis
Journal: Current Pharmaceutical Design
Volume: 30 Issue: 12 Year: 2024 Page: 887-901
Author(s):
Trichothecenes: Structure-Toxic Activity Relationships
Journal: Current Drug Metabolism
Volume: 14 Issue: 6 Year: 2013 Page: 641-660
Author(s): Qinghua Wu, Vlastimil Dohnal, Kami Kuca, Zonghui Yuan
Adenosine Deaminase in the Modulation of Immune System and its Potential as a Novel Target for Treatment of Inflammatory Disorders
Journal: Current Drug Targets
Volume: 13 Issue: 6 Year: 2012 Page: 842-862
Author(s): Luca Antonioli,Rocchina Colucci,Concettina La Motta,Marco Tuccori,Oriana Awwad,Federico Da Settimo,Corrado Blandizzi,Matteo Fornai
Finding the Smoking Gun: Protein Tyrosine Phosphatases as Tools and Targets of Unicellular Microorganisms and Viruses
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 10 Year: 2012 Page: 1530-1566
Author(s): P. Heneberg
Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7 Issue: 1 Year: 2007 Page: 35-63
Author(s): C. Kleinschnitz, S. G. Meuth, B. C. Kieseier, H. Wiendl
Cancer Vaccines in Phase II/III Clinical Trials: State of the Art and Future Perspectives
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 85-102
Author(s): S. Cecco, E. Muraro, E. Giacomin, D. Martorelli, R. Lazzarini, P. Baldo, R. Dolcetti
From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis
Journal: Current Neuropharmacology
Volume: 15 Issue: 6 Year: 2017 Page: 874-891
Author(s): Lilian Aly,Bernhard Hemmer,Thomas Korn